These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 22724878)

  • 21. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.
    Wieckowska A; Papouchado BG; Li Z; Lopez R; Zein NN; Feldstein AE
    Am J Gastroenterol; 2008 Jun; 103(6):1372-9. PubMed ID: 18510618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease.
    McCullough AJ
    Clin Liver Dis; 2004 Aug; 8(3):521-33, viii. PubMed ID: 15331061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Markers of activated inflammatory cells correlate with severity of liver damage in children with nonalcoholic fatty liver disease.
    De Vito R; Alisi A; Masotti A; Ceccarelli S; Panera N; Citti A; Salata M; Valenti L; Feldstein AE; Nobili V
    Int J Mol Med; 2012 Jul; 30(1):49-56. PubMed ID: 22505182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Helicobacter pylori infection in patients with nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Papatheodorou A; Patsiaoura K; Katsiki E; Zafeiriadou E; Zavos C; Anastasiadou K; Terpos E
    Metabolism; 2013 Jan; 62(1):121-6. PubMed ID: 22841522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years.
    Furuya CK; de Oliveira CP; de Mello ES; Faintuch J; Raskovski A; Matsuda M; Vezozzo DC; Halpern A; Garrido AB; Alves VA; Carrilho FJ
    J Gastroenterol Hepatol; 2007 Apr; 22(4):510-4. PubMed ID: 17376042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Automatic quantification of lobular inflammation and hepatocyte ballooning in nonalcoholic fatty liver disease liver biopsies.
    Vanderbeck S; Bockhorst J; Kleiner D; Komorowski R; Chalasani N; Gawrieh S
    Hum Pathol; 2015 May; 46(5):767-75. PubMed ID: 25776030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: a pilot study.
    Lee YM; Low HC; Lim LG; Dan YY; Aung MO; Cheng CL; Wee A; Lim SG; Ho KY
    Gastrointest Endosc; 2012 Oct; 76(4):756-60. PubMed ID: 22840293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years.
    Wong VW; Wong GL; Choi PC; Chan AW; Li MK; Chan HY; Chim AM; Yu J; Sung JJ; Chan HL
    Gut; 2010 Jul; 59(7):969-74. PubMed ID: 20581244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apoptosis markers in liver biopsy of nonalcoholic steatohepatitis in pediatric patients.
    Valva P; De Matteo E; Galoppo M; Pedreira A; Giacove G; Lezama C; Marco I; Galoppo MC; Preciado MV
    Hum Pathol; 2008 Dec; 39(12):1816-22. PubMed ID: 18715620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
    Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
    Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visceral adiposity index is not a predictor of liver histology in patients with non-alcoholic fatty liver disease.
    Vongsuvanh R; George J; McLeod D; van der Poorten D
    J Hepatol; 2012 Aug; 57(2):392-8. PubMed ID: 22521350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease.
    Hossain N; Afendy A; Stepanova M; Nader F; Srishord M; Rafiq N; Goodman Z; Younossi Z
    Clin Gastroenterol Hepatol; 2009 Nov; 7(11):1224-9, 1229.e1-2. PubMed ID: 19559819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generalizability of the nonalcoholic steatohepatitis Clinical Research Network histologic scoring system for nonalcoholic fatty liver disease.
    Juluri R; Vuppalanchi R; Olson J; Unalp A; Van Natta ML; Cummings OW; Tonascia J; Chalasani N
    J Clin Gastroenterol; 2011 Jan; 45(1):55-8. PubMed ID: 20505526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective.
    Lackner C
    Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):223-31. PubMed ID: 21476917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.
    Mofrad P; Contos MJ; Haque M; Sargeant C; Fisher RA; Luketic VA; Sterling RK; Shiffman ML; Stravitz RT; Sanyal AJ
    Hepatology; 2003 Jun; 37(6):1286-92. PubMed ID: 12774006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction.
    Richardson MM; Jonsson JR; Powell EE; Brunt EM; Neuschwander-Tetri BA; Bhathal PS; Dixon JB; Weltman MD; Tilg H; Moschen AR; Purdie DM; Demetris AJ; Clouston AD
    Gastroenterology; 2007 Jul; 133(1):80-90. PubMed ID: 17631134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
    Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G
    Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of liver biopsy in the diagnosis of NASH].
    Kanemasa K; Sumida Y
    Nihon Rinsho; 2006 Jun; 64(6):1119-25. PubMed ID: 16768119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies.
    Adams LA; Sanderson S; Lindor KD; Angulo P
    J Hepatol; 2005 Jan; 42(1):132-8. PubMed ID: 15629518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proposal for a histological scoring and grading system for non-alcoholic fatty liver disease.
    Mendler MH; Kanel G; Govindarajan S
    Liver Int; 2005 Apr; 25(2):294-304. PubMed ID: 15780053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.